missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ MRPL14 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA551008
This item is not returnable.
View return policy
Description
MRPL14 Polyclonal Antibody detects endogenous levels of MRPL14 protein.
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. A pseudogene corresponding to this gene is found at 17p13.3.
Specifications
| MRPL14 | |
| Polyclonal | |
| Unconjugated | |
| Mrpl14 | |
| 1110006I11Rik; 39S ribosomal protein L14, mitochondrial; 39S ribosomal protein L32, mitochondrial; AI846816; L14mt; L32mt; Mitochondrial large ribosomal subunit protein uL14m; mitochondrial ribosomal protein L14; mitochondrial ribosomal protein L32; Mrpl14; MRP-L14; MRPL32; MRP-L32; RMPL32; Rpml32 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 301250, 64928, 68463 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Immunohistochemistry, Western Blot | |
| 1 mg/mL | |
| PBS with 0.5% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| Q6P1L8, Q7M0E7, Q9D1I6 | |
| Mrpl14 | |
| Synthesized peptide derived from the C-terminal region of human MRP-L14. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction